Who owns the VETVEDA trademark?

The VETVEDA trademark is owned by Bioved Pharmaceuticals, Inc.

What class is the VETVEDA trademark registered in?

The VETVEDA trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for VETVEDA?

The USPTO serial number for VETVEDA is 97664604.

What is the registration number for VETVEDA?

VETVEDA is registered under USPTO registration number 7590080.

Sealvo

Home Search: VETVEDAVETVEDA #97664604

Back

Updated Oct 23, 2026·10 searches this week

View on USPTO TSDR Find similar marks

VET

USPTO Trademark Record

REGISTERED

VETVEDA

SN 97664604·Reg 7590080·Filed Nov 06, 2022

Owner Bioved Pharmaceuticals, Inc

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

VETVEDA (Serial No. 97664604), Registration No. 7590080, is a registered US trademark filed on Nov 06, 2022 by Bioved Pharmaceuticals, Inc. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: December 03, 2030

Mark Intelligence

VETVEDA (Reg. #7590080) is a registered US trademark that has been protecting its owner, Bioved Pharmaceuticals, Inc, since 2022. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Nov 06, 2022

SERIAL

97664604

REG#

7590080

REGISTERED

Dec 03, 2024

Filing Information

StatusREGISTERED

Filing DateNov 06, 2022

Serial Number97664604

Registration No.7590080

Registration DateDec 03, 2024

Status DateDec 03, 2024

Published for OppositionJan 16, 2024

Filing Basis & Declarations

Standard Characters ClaimedUse Application CurrentlyTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Oct 30, 2022

First use in commerce: Aug 15, 2024

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

23 events

REGISTERED-PRINCIPAL REGISTER

Dec 03, 2024

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Dec 03, 2024

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Nov 14, 2024

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Nov 14, 2024

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Nov 13, 2024

CASE ASSIGNED TO INTENT TO USE PARALEGAL

STATEMENT OF USE PROCESSING COMPLETE

Nov 13, 2024

STATEMENT OF USE PROCESSING COMPLETE

TEAS STATEMENT OF USE RECEIVED

Sep 11, 2024

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Sep 11, 2024

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Mar 12, 2024

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Jan 16, 2024

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jan 16, 2024

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Dec 27, 2023

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Dec 08, 2023

APPROVED FOR PUB - PRINCIPAL REGISTER

EXAMINERS AMENDMENT E-MAILED

Dec 08, 2023

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Dec 08, 2023

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Dec 08, 2023

EXAMINER'S AMENDMENT ENTERED

EXAMINERS AMENDMENT -WRITTEN

Dec 08, 2023

EXAMINERS AMENDMENT -WRITTEN

NON-FINAL ACTION WRITTEN

Aug 23, 2023

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Aug 23, 2023

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Aug 23, 2023

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Aug 21, 2023

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Nov 23, 2022

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Nov 09, 2022

NEW APPLICATION ENTERED

Other Marks by Bioved Pharmaceuticals, Inc

Additional USPTO filings from the same owner.

ART

ARTREX

99534518

BIO-VED Pharmaceuticals, Inc.

REGISTERED

ANI

ANITREX

88629650

Bioved Pharmaceuticals, Inc.

REGISTERED

BIO

BIOVED PHARMACEUTICALS, INC.

98384761

Bioved Pharmaceuticals, Inc.

REGISTERED

SHW

SHWAN AYURVED

90814818

Bioved Pharmaceuticals, Inc.

REGISTERED

Other Marks by Mark Farrell

Additional USPTO filings handled by the same attorney of record.

ANI

ANITREX

88629650

REGISTERED

BIO

BIOVED PHARMACEUTICALS, INC.

98384761

REGISTERED

AVA

AVANTERRA

97912748

REGISTERED

NEX

NEXT WORLD WINES

97888587

REGISTERED

VETVEDA

Run a conflict check

Other Marks by Bioved Pharmaceuticals, Inc

Other Marks by Mark Farrell

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company